Can't argue the ATH (~AU$600m) was achieved during the COVID pump - as to whether we hit overpriced territory, that could be debated. I think one issue we're facing is that holders look at the SP at that time and incorrectly anchor a fair valuation at something less than this, as they probably do with the others you've listed (also, the stocks you reference are currently down >90% - RAC never got close to this fall off).
No fair value model I've considered comes anywhere near as low as AU$600m today. FWIW - MST Access currently value RAC at ~AU$450m. So, perhaps I'm the idiot.
Fair (peer) valuation would be sooo much easier if Storm Therapeutics was listed
Can't argue the ATH (~AU$600m) was achieved during the COVID...
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
-0.060(4.00%) |
Mkt cap ! $245.4M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.44 | $57.11K | 38.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2499 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 247 | 1 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |